Dementia Big
Biomarkers that identify individuals at risk of Alzheimer’s disease (AD) development would be highly valuable. Plasma concentration of amyloid-β (Aβ)—central in the pathogenesis of AD—is a logical candidate, but studies to date have produced conflicting results on its utility.
http://ift.tt/2dcgpxP
No comments:
Post a Comment